INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 50 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $10,000 | -33.3% | 13,000 | -23.5% | 0.00% | – |
| Q1 2020 | $15,000 | -40.0% | 17,000 | -32.6% | 0.00% | – |
| Q4 2019 | $25,000 | +38.9% | 25,208 | +41.4% | 0.00% | – |
| Q2 2019 | $18,000 | -43.8% | 17,832 | -55.4% | 0.00% | – |
| Q1 2018 | $32,000 | -78.7% | 40,000 | -78.4% | 0.00% | – |
| Q4 2017 | $150,000 | – | 185,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $56,098,000 | 1.12% |
| L & S Advisors Inc | 795,000 | $767,000 | 0.14% |
| OAKTREE CAPITAL MANAGEMENT LP | 9,964,000 | $9,690,000 | 0.11% |
| WEDBUSH SECURITIES INC | 13,000 | $1,251,000 | 0.07% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,163,000 | $3,076,000 | 0.06% |
| ZAZOVE ASSOCIATES LLC | 246,000 | $240,000 | 0.02% |
| Balboa Wealth Partners | 21,000 | $20 | 0.01% |
| Russell Investments Group, Ltd. | 1,910,000 | $1,875,000 | 0.00% |
| GAMCO INVESTORS, INC. ET AL | 250,000 | $244,000 | 0.00% |
| Regal Investment Advisors LLC | 20,000 | $19,000 | 0.00% |